NIT
PBYI icon

NumerixS Investment Technologies’s Puma Biotechnology PBYI Stock Holding History

NumerixS Investment Technologies’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,004
Closed -$52K – 607
2020
Q2 		$52K Buy
+5,004
New +$51.8K 0.01% 788
2020
Q1 		– Sell
-19,009
Closed -$166K – 1210
2019
Q4 		$166K Buy
19,009
+15,900
+511% +$132K 0.03% 540
2019
Q3 		$33K Sell
3,109
-16,736
-84% -$181K 0.01% 809
2019
Q2 		$252K Buy
19,845
+19,245
+3,208% +$443K 0.07% 340
2019
Q1 		$24K Sell
600
-1,539
-72% -$47K ﹤0.01% 1055
2018
Q4 		$45K Buy
2,139
+1,939
+970% +$58.2K 0.01% 794
2018
Q3 		$9K Sell
200
-2,300
-92% -$111K ﹤0.01% 1139
2018
Q2 		$141K Buy
+2,500
New +$145K 0.03% 635
2017
Q1 		– Sell
-200
Closed -$6K – 1310
2016
Q4 		$6K Buy
+200
New +$8.65K ﹤0.01% 1074
2015
Q3 		– Sell
-7,057
Closed -$824K – 746
2015
Q2 		$824K Buy
7,057
+4,257
+152% +$771K 0.11% 240
2015
Q1 		$661K Sell
2,800
-100
-3% -$21.4K 0.12% 234
2014
Q4 		$549K Buy
+2,900
New +$643K 0.19% 159

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NumerixS Investment Technologies's PBYI Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Puma Biotechnology (PBYI) in Q3 2020, closing a stake of 5,004 shares — an estimated $52K sold.

NumerixS Investment Technologies first reported a position in PBYI in Q4 2014 and held it in 12 quarters. The position peaked at $824K in Q2 2015. 128 funds tracked by Wall St. Rank hold PBYI as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Puma Biotechnology position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 5,004 Puma Biotechnology shares in Q3 2020, an estimated $52K.
  • NumerixS Investment Technologies first reported a position in Puma Biotechnology in Q4 2014 and held it in 12 quarters.
  • NumerixS Investment Technologies's Puma Biotechnology position peaked at $824K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.